Aytu Biopharma AYTU
NASDAQ AYTU
$2.07 -0.02 (-0.94%)
As of: Oct 2, 2026 · 1:36 PM EDT

Aytu Biopharma (AYTU) Non-Current Deffered Revenue (2015 - 2016)

Updated

Aytu Biopharma (AYTU) posted Non-Current Deffered Revenue of $361,607 for fiscal Q3 2016 (quarter ended Mar 31, 2016), down 5.6% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Non-Current Deffered Revenue (2015 - 2016) Analysis & Trends

At the end of FY2015 (ended Jun 30, 2015), Aytu Biopharma's Non-Current Deffered Revenue came in at $425,893, down 16.8% from FY2014.

  • In prior fiscal years, Aytu Biopharma's Non-Current Deffered Revenue was $511,607 in FY2014.
  • According to Business Quant data, Non-Current Deffered Revenue for the three prior fiscal quarters was $383,036 (Q2 2016), $404,465 (Q1 2016) and $425,893 (Q4 2015).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Aytu Biopharma 23.25 Mn -92.42 Mn 10.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2016 361,607.00
Dec 31, 2015 383,036.00
Sep 30, 2015 404,465.00
Jun 30, 2015 425,893.00
API Access

Aytu Biopharma Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=AYTU&period=max&api_key=YOUR_API_KEY